Clinical Topics & News

308-nm UVB Excimer Laser Versus Nontargeted Phototherapy

From Dermatology, Pathology, and Public Health Sciences at the Wake Forest University School of Medicine in Winston-Salem, North Carolina.

Dr. Feldman discusses UVB phototherapy for the treatment of psoriasis. For more information, read Dr. Feldman's article from the September 2012 issue, "Therapeutic Modalities for Localized Psoriasis: 308-nm UVB Excimer Laser Versus Nontargeted Phototherapy."


 

Recommended Reading

Experience Proved Rituximab Best for Vasculitis
Psoriasis Collection
Psoriasis Plus Diabetes Equals Heightened Vascular Risk
Psoriasis Collection
EULAR's Lupus Nephritis Guidelines Emphasize Early Biopsy
Psoriasis Collection
Psoriasis Flares Rapidly Postpartum
Psoriasis Collection
Psoriasis: Short-Course Clobetasol Enhances Etanercept Outcomes
Psoriasis Collection
Indirect Comparison Trial Favors Adalimumab for Psoriasis
Psoriasis Collection
Game Changer? First JAK Inhibitor Approved for Rheumatoid Arthritis
Psoriasis Collection
Secukinumab Tames Hand, Foot Psoriasis
Psoriasis Collection
Oral JAK Inhibitor's Clinical Place To Be Determined
Psoriasis Collection
Adalimumab for the Treatment of Pityriasis Rubra Pilaris: A Case Report
Psoriasis Collection